Literature DB >> 4960899

In vitro and in vivo characterization of pyocin.

T B Higerd, C A Baechler, R S Berk.   

Abstract

Pyocin, a bacteriocin obtained from lysates of ultraviolet-induced cultures of Pseudomonas aeruginosa was characterized in vitro and in vivo after 1,000-fold purification by chemical, column, and differential centrifugation procedures. Electron micrographs of negatively stained pyocin preparations contained rod-shaped particles which resembled the contractile tail protein of the T-even phages of Escherichia coli. Although two separate and distinct pyocin fractions were eluted from diethylaminoethyl cellulose (pH 7.5) during the purification procedure, the particles appeared identical. In addition, the two fractions exhibited a close correlation between their titers and the particle numbers as observed in the electron microscope. The particles were approximately 20 by 90 mmu with a core diameter of 5 mmu and a sheath length of 50 mmu. Neither intact phage nor ghosts were seen in any of the preparations, although ringlets of two different diameters, which appeared to correspond to the diameters of the sheath and inner core, were observed. Other studies indicated that, although crude preparations were stable to freezing and thawing, purified preparations lost all of their activity under similar treatment. However, the addition of 50% glycerol to purified preparations completely protected activity. Conversely, aged normal human or rabbit sera enhanced the antibacterial activity of pyocin approximately fourfold, although serum albumin and hemoglobin had no effect. In vivo studies indicated that purified pyocin was not lethal for mice when injected intraperitoneally in concentrations of 28,000 to 1,400,000 units (5.6 to 276 mug of protein), nor was 7,200 to 36,000 units dermonecrotic for rabbits.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4960899      PMCID: PMC276718          DOI: 10.1128/jb.93.6.1976-1986.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  STUDIES OF A PYOCIN. II. MODE OF PRODUCTION OF THE PYOCIN.

Authors:  K IKEDA; M KAGEYAMA; F EGAMI
Journal:  J Biochem       Date:  1964-01       Impact factor: 3.387

2.  Automatic analysis of tissue culture proteins with stable Folin reagents.

Authors:  B ZAK; J COHEN
Journal:  Clin Chim Acta       Date:  1961-09       Impact factor: 3.786

3.  Study of the properties of seven defective-lysogenic strains derived from Escherichia coli K12 (lambda).

Authors:  W ARBER; G KELLENBERGER
Journal:  Virology       Date:  1958-06       Impact factor: 3.616

4.  The fine structure of a pyocin.

Authors:  S I Ishii; Y Nishi; F Egami
Journal:  J Mol Biol       Date:  1965-09       Impact factor: 5.469

5.  A rod-shaped Pseudomonas phage.

Authors:  K Takeya; K Amako
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

6.  Colicine K and endotoxins: effect of hemoglobin and its subunits on their antibiotic and serological properties.

Authors:  H Van Vunakis; A Ruffilli; L Levine
Journal:  Biochem Biophys Res Commun       Date:  1964-07-01       Impact factor: 3.575

7.  Structure of mutator phage Mu1 of Escherichia coli.

Authors:  C M To; A Eisenstark; H Töreci
Journal:  J Ultrastruct Res       Date:  1966-03

8.  Electron microscopy of the anti-bacterial agent produced by Escherichia coli 15.

Authors:  H D Mennigmann
Journal:  J Gen Microbiol       Date:  1965-11

9.  "CELL-WALL PROTEIN A" OF PSEUDOMONAS AERUGINOSA AND ITS RELATIONSHIP TO "ORIGINAL ENDOTOXIN PROTEIN".

Authors:  J Y HOMMA; N SUZUKI
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

10.  Electron densitometry of stained virus particles.

Authors:  C E HALL
Journal:  J Biophys Biochem Cytol       Date:  1955-01
View more
  17 in total

Review 1.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Authors:  Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

2.  Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.

Authors:  Michelle D Brazas; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Electron microscopy of particles associated with a bacteriocinogenic Vibrio cholerae strain.

Authors:  D Lang; T O McDonald; E W Gardner
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

4.  In vitro pyocin activity of Pseudomonas aeruginosa strains pretreated with antibiotics.

Authors:  F Y Al-Ani; A S Al-Shibib
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

5.  Purification and characterization of pyocins from Pseudomonas aeruginosa.

Authors:  A Al-Shibib; S Al-Mudhaffar; F Al-Ani; F Hassan
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

6.  Purification and characterization of pyocins R from Pseudomonas aeruginosa.

Authors:  R al-Rubiee; S al-Mudaffar; F Hassan; F al-Ani
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

7.  Defective pyocin particles produced by some mutant strains of Pseudomonas aeruginosa.

Authors:  T Shinomiya; M Osumi; M Kageyama
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

8.  Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice.

Authors:  D J Merrikin; C S Terry
Journal:  Appl Microbiol       Date:  1972-01

Review 9.  Genetics of Pseudomonas.

Authors:  B W Holloway
Journal:  Bacteriol Rev       Date:  1969-09

10.  Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool.

Authors:  H D Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.